Lantern Pharma Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q2 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Lantern Pharma Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q2 2021 to Q2 2024.
  • Lantern Pharma Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $213K, a 30.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $213K -$95.2K -30.9% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $187K -$68.1K -26.7% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $228K +$181K +379% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $269K +$186K +224% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $308K +$191K +162% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $255K +$103K +67.9% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $47.7K -$138K -74.4% Dec 31, 2022 10-K 2024-03-18
Q3 2022 $82.9K -$137K -62.2% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $118K -$135K -53.4% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $152K Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $186K Dec 31, 2021 10-K 2024-03-18
Q3 2021 $219K Sep 30, 2021 10-Q 2021-11-01
Q2 2021 $253K Jun 30, 2021 10-Q 2021-07-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.